Literature DB >> 12110525

Genetic approaches to the molecular understanding of type 2 diabetes.

Mark I McCarthy1, Philippe Froguel.   

Abstract

The appreciation that individual susceptibility to type 2 diabetes (T2D) and related components of the dysmetabolic syndrome has a strong inherited component provides a coherent framework within which to develop a molecular understanding of the pathogenesis of T2D. This review focuses on the main approaches currently adopted by researchers seeking to identify the inherited basis of T2D and the present state of our knowledge. One central theme that emerges is that progress in defining the genetic basis of the common, multifactorial forms of T2D is hindered by etiological heterogeneity: T2D is likely to represent the final common pathway of diverse interacting primary disturbances. Such heterogeneity equally compromises efforts to understand the basis for T2D by use of other approaches, such as cellular biochemistry and classical physiology. Analyses that seek to ally sophisticated physiological characterization with measures of genomic variation are likely to provide powerful tools for redressing the loss of power associated with such heterogeneity.

Entities:  

Mesh:

Year:  2002        PMID: 12110525     DOI: 10.1152/ajpendo.00099.2002

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  29 in total

Review 1.  The epidemiology of lifestyle and risk for type 2 diabetes.

Authors:  Rob M van Dam
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

2.  Developing multi-faith chaplaincy.

Authors:  A R Gatrad; E Brown; A Sheikh
Journal:  Arch Dis Child       Date:  2004-06       Impact factor: 3.791

3.  Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics.

Authors:  Nicolai M Doliba; Wei Qin; Habiba Najafi; Chengyang Liu; Carol W Buettger; Johanna Sotiris; Heather W Collins; Changhong Li; Charles A Stanley; David F Wilson; Joseph Grimsby; Ramakanth Sarabu; Ali Naji; Franz M Matschinsky
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-09-27       Impact factor: 4.310

Review 4.  Epigenetic phenomena linked to diabetic complications.

Authors:  Luciano Pirola; Aneta Balcerczyk; Jun Okabe; Assam El-Osta
Journal:  Nat Rev Endocrinol       Date:  2010-11-02       Impact factor: 43.330

5.  A genomics study of type 2 diabetes mellitus in U.S. Air Force personnel.

Authors:  Lisa Lott
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

6.  The possible role of 10398A and 16189C mtDNA variants in providing susceptibility to T2DM in two North Indian populations: a replicative study.

Authors:  Audesh Bhat; Anil Koul; Swarkar Sharma; Ekta Rai; S I A Bukhari; M K Dhar; R N K Bamezai
Journal:  Hum Genet       Date:  2006-10-26       Impact factor: 4.132

7.  Association study of genetic polymorphisms of SLC2A10 gene and type 2 diabetes in the Taiwanese population.

Authors:  W H Lin; L M Chuang; C H Chen; J I Yeh; P S Hsieh; C H Cheng; Y T Chen
Journal:  Diabetologia       Date:  2006-04-04       Impact factor: 10.122

8.  The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3.

Authors:  Haruhiko Osawa; Kazuya Yamada; Hiroshi Onuma; Akiko Murakami; Masaaki Ochi; Hiroko Kawata; Tatsuya Nishimiya; Toshiyuki Niiya; Ikki Shimizu; Wataru Nishida; Mitsuru Hashiramoto; Azuma Kanatsuka; Yasuhisa Fujii; Jun Ohashi; Hideichi Makino
Journal:  Am J Hum Genet       Date:  2004-08-26       Impact factor: 11.025

9.  Dimension reduction for mapping mRNA abundance as quantitative traits.

Authors:  Hong Lan; Jonathan P Stoehr; Samuel T Nadler; Kathryn L Schueler; Brian S Yandell; Alan D Attie
Journal:  Genetics       Date:  2003-08       Impact factor: 4.562

Review 10.  The genetics and pathophysiology of diabetes mellitus type II.

Authors:  A B Jenkins; L V Campbell
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.